Ointment texture analysis is the instrumented measurement of consistency, firmness, adhesiveness and spreadability of pharmaceutical ointments using a texture analyzer equipped with a back extrusion cell, cone penetrometer and/or spreadability rig. For topical ointments — the hydrocarbon-based, anhydrous or water-in-oil emulsion semi-solids covered under USP <1724> Semi-Solid Drug Products — Performance Tests and the classical ASTM D217 cone penetration method — texture analysis delivers an objective, electronic-record-compliant readout of product consistency that is far more sensitive and reproducible than the visual or gravimetric methods it replaced. On the KHT TA-30, a single platform with interchangeable fixtures produces back extrusion force curves, cone penetration depth and 90°/45° spreadability energy within a 0.1–50 N force envelope at 0.01 N resolution, covering the full range of pharmaceutical ointments from soft hydroalcoholic bases to stiff petrolatum and zinc oxide formulations.
Ointment Texture Properties and Their Formulation Significance
Pharmaceutical ointments span a wide consistency range — from soft, easily spreadable hydrocarbon bases to stiff, gritty medicated pastes — and each consistency class demands a specific measurement geometry. Five texture properties dominate ointment characterisation: firmness (yield force), adhesiveness (withdrawal work), cohesiveness (TPA ratio), spreadability (Ortan energy) and apparent viscosity (back extrusion steady-state force). The first three are tightly linked to patient experience of the product; the last two drive process engineering and tube-filling behaviour.
Firmness controls how much force the patient must apply to extrude product from a tube and how readily it flows under the fingertip. Too-firm ointments (>30 N peak extrusion force in a 45 mm back extrusion cell) produce poor patient compliance; too-soft ointments (<3 N peak) tend to leak from tubes during warm shipping. Adhesiveness governs how long the ointment stays in contact with skin after application — a critical parameter for wound-care and corticosteroid ointments where residence time determines therapeutic dose. Cohesiveness is the structural integrity of the ointment: high-cohesiveness products re-form into a single mass after deformation, while low-cohesiveness products crumble or separate.
Spreadability is the most directly patient-perceived property and often the most heavily specified in release testing. For ointments it is usually measured with a 45° Ortan cone (the 45° steep angle handles the stiffer force envelope typical of ointments better than the 90° shallow geometry). Apparent viscosity, measured via back extrusion, correlates with tube-filling machine settings, cooling rate sensitivity and pourability at process temperatures.
Regulatory programmes — particularly US topical generic bioequivalence (Q3 microstructural sameness) and EU Annex 15 in-process control — now expect multi-parameter texture data as part of a complete ointment specification. A single "consistency" number no longer satisfies reviewers. A modern pharmaceutical ointment release specification typically lists peak back extrusion force, spreadability energy (45° cone), and at least one TPA parameter (usually cohesiveness), each with defined acceptance ranges derived from process validation batches.
Choosing the Right Texture Analyzer Method for Ointment QC
Four methods cover virtually all pharmaceutical ointment texture analysis requirements. The choice depends on product consistency, available sample mass, and whether the specification prioritises patient-perceived application behaviour or process/filling behaviour.
Back extrusion is the go-to method for stiff and medium-consistency ointments. A flat disc (typically 35 mm or 45 mm) is driven at 1.0 mm/s into a cylindrical cell filled with product. Product flows upward through the annular gap between disc and cell wall. The force curve exhibits a yield peak followed by a steady-state plateau; both are reportable parameters. Back extrusion is more reproducible than a flat probe for stiff products because the bounded flow geometry prevents product fracture and side spreading.
Cone penetrometry (ASTM D217-equivalent) is the classical ointment test and is cross-referenced in pharmacopoeial practice. A 45° standard cone is driven into the product at a controlled speed (0.5–2.0 mm/s) for a defined travel or until a force plateau is reached. Penetration depth at a defined peak force, or peak force at a defined depth, is reported. Cone penetrometry is particularly well-suited to anhydrous petrolatum-based ointments where ASTM legacy data is available for benchmarking.
Spreadability rig (45° Ortan) measures the work of spreading — patient-perceived ease of application. The 45° geometry is preferred over the 90° for ointments because the steeper angle handles the higher force envelope (2–20 N typical) and is less prone to side leakage. Sample mass: 10–12 g. Test travel: 15 mm. See the pharmaceutical gel spreadability test page for the shared Ortan method details.
Texture Profile Analysis (TPA) — double-compression with a flat 25 mm or 35 mm probe — delivers the widest slate of parameters (hardness, cohesiveness, springiness, adhesiveness, gumminess) from a single test. TPA is the preferred method for W/O emulsion ointments and medicated petrolatum bases where the multiple parameters capture both structural and flow behaviour.
A simple selection rule: for stiff anhydrous ointments (peak back extrusion force >15 N), start with back extrusion + cone penetrometry. For soft-to-medium ointments (peak force 3–15 N), start with TPA + spreadability rig. For full characterisation of a new ointment formulation, run all four methods during method development, then down-select to the two most discriminating methods for routine QC.
Budget instruments frequently support only one or two of these four geometries, forcing labs to compromise on method choice. The KHT TA-30 ships with all four methods pre-built in its method library and with the full fixture set transparently priced.
Test Protocol: Back Extrusion, Cone Penetration & Spreadability
The following consolidated protocol defines the KHT TA-30 standard method parameters for routine pharmaceutical ointment QC.
Sample preparation (all methods): Condition 25–50 g of product at 25.0 ± 0.5 °C for a minimum of 4 hours. Transfer to the appropriate test vessel without air entrainment. For temperature-sensitive waxy ointments, extend conditioning to 12 hours or use the Peltier platform at 25 °C.
Back extrusion setup:
- Fixture: 45 mm flat disc in 50 mm cylindrical cell (or 35 mm disc in 40 mm cell for low-viscosity bases)
- Load cell: 5 kg (or 10 kg for heavy zinc oxide pastes)
- Speed: 1.0 mm/s
- Travel: 25 mm
- Trigger: 0.1 N
- Data rate: 500 Hz
- Sample: fill cell to 30 mm depth
- Replicates: 5
Cone penetrometry setup:
- Fixture: 45° stainless steel cone (50 g standard)
- Speed: 1.0 mm/s driven (or free-fall variant for ASTM D217 compliance)
- Travel: 10 mm
- Trigger: 0.05 N
- Data rate: 500 Hz
- Sample: minimum 50 mm depth in sample cup, surface smoothed
- Replicates: 5
Spreadability rig (45°):
- Fixture: 45° matched male/female Ortan cones
- Speed: 3.0 mm/s
- Travel: 15 mm
- Trigger: 0.05 N
- Data rate: 500 Hz
- Sample: 10–12 g
- Replicates: 5
TPA (back-up method):
- Fixture: 25 or 35 mm flat cylindrical probe
- Speed: 1.0 mm/s
- Compression: 40–50% strain, 5 s dwell between bites
- Trigger: 0.05 N
- Data rate: 500 Hz
- Sample: 30–40 g in 50 mm dia container
- Replicates: 5
Data Parameters: Firmness, Cohesiveness, Adhesive Force & Work
A routine pharmaceutical ointment QC report extracts the following parameters. Typical ranges are provided for a mid-consistency petrolatum-based ointment at 25 °C on the KHT TA-30.
| Parameter | Method | Definition | Typical Range |
|---|---|---|---|
| Peak extrusion force (Firmness) | Back extrusion, 45 mm disc | Maximum force during descent | 5–30 N |
| Steady-state extrusion force | Back extrusion, 45 mm disc | Mean force over 10–20 mm travel | 3–20 N |
| Cone penetration depth | Cone penetrometry | Distance at defined force (0.5 N) | 3–12 mm |
| Peak force at 10 mm | Cone penetrometry | Force at fixed depth | 0.5–5 N |
| Spreadability energy | 45° Ortan rig | Area under force-distance curve | 20–200 N·mm |
| Peak spreadability force | 45° Ortan rig | Maximum force during descent | 2–20 N |
| Firmness (TPA hardness) | TPA, 25 mm probe | Peak force, 1st bite | 2–30 N |
| Cohesiveness | TPA | A2/A1 | 0.3–0.6 |
| Springiness | TPA | Recovered / original distance | 0.3–0.7 |
| Adhesiveness | TPA | Negative area during 1st withdrawal | 0.5–5 N·s |
| Work of adhesion | TPA | Integrated negative area | 0.3–4 N·mm |
A pharmaceutical ointment release specification typically names three to five of these parameters with mean ± range acceptance criteria derived from the three process validation batches. Example specification for a generic zinc oxide ointment: peak back extrusion force 12.5 ± 3.0 N; spreadability energy (45°) 65 ± 15 N·mm; TPA cohesiveness 0.45 ± 0.10.
Setting Specification Limits and Interpreting Batch-to-Batch Variation
Specification setting for ointment texture parameters follows a three-stage process: process validation batches (PV1–3), capability assessment (Cp / Cpk), and specification window selection (typically mean ± 3σ, constrained by clinical relevance).
In routine QC, out-of-specification (OOS) results in ointment texture testing most commonly trace to four root causes:
- Temperature drift. A 5 °C rise softens a typical petrolatum ointment by 15–25%. Verify conditioning time and platform temperature before repeating. Peltier-stabilised testing eliminates this class of errors.
- Cooling-rate deviation during manufacture. Faster cooling produces smaller fat crystals and firmer ointments; slower cooling yields coarser crystals and softer ointments. A systematic drift in all batches from one manufacturing line points here.
- Mixing-shear deviation. Over-shearing breaks down emulsion droplets and lowers firmness; under-shearing leaves heterogeneous structure and produces high %RSD within replicates.
- Raw material specification drift. Wax chain length, petrolatum grade and emulsifier HLB all strongly affect texture. A persistent shift across multiple batches after a raw-material lot change points here.
Good QC practice is to log texture parameters on a statistical process control (SPC) chart; trends are often detectable 3–5 batches before a batch goes OOS. The KHT TA-30 software exports directly to SPC chart templates and to most LIMS systems via signed XML.
A cost note on multi-facility ointment manufacturing. For companies running the same formulation at two or more sites, method reproducibility across instruments is a major concern. The KHT TA-30 SOP lock-down feature standardises all method parameters (speed, trigger, data rate, fixture, calibration) across instruments, producing inter-site %RSD typically below 8%. Enterprise brands generally require separate paid-service cross-correlation studies ($3,000–$8,000 per site pair) to achieve comparable inter-lab agreement. For the full multi-site validation package, see the KHT TA-30 product page.
Test Method Details
| Parameter | Back Extrusion | Cone Penetrometry | Spreadability (45°) | TPA |
|---|---|---|---|---|
| Sample mass | 30–80 g | 50+ g | 10–12 g | 30–40 g |
| Fixture | 45 mm disc + 50 mm cell | 45° cone | 45° matched cones | 25/35 mm flat probe |
| Test speed | 1.0 mm/s | 1.0 mm/s (driven) | 3.0 mm/s | 1.0 mm/s |
| Travel | 25 mm | 10 mm | 15 mm | 40–50% strain |
| Force range | 0.5–50 N | 0.1–10 N | 1–20 N | 0.5–30 N |
| Temperature | 25.0 ± 0.5 °C | 25.0 ± 0.5 °C | 25.0 ± 0.5 °C | 25.0 ± 0.5 °C |
Key TPA Parameters for Semi-Solids
For ointments tested by TPA, the key parameters and their QC meaning are summarised below:
| TPA Parameter | Typical Ointment Range | QC Interpretation |
|---|---|---|
| Hardness | 2–30 N | Primary consistency indicator |
| Cohesiveness | 0.3–0.6 | Structural integrity; low values indicate crumbling/phase separation |
| Springiness | 0.3–0.7 | Elastic recovery; drops with over-shear |
| Adhesiveness | 0.5–5 N·s | Skin substantivity |
| Gumminess | 0.6–18 N | "Body" or chewing resistance — borrowed from food TPA |
| Resilience | 0.05–0.3 | Early elastic response |
Step-by-Step Protocol
The following is the KHT TA-30 standard protocol for routine back-extrusion-based ointment QC. Protocols for cone penetrometry and TPA are available in the method library with analogous steps.
- Sample conditioning. Condition product at 25.0 ± 0.5 °C for a minimum of 4 hours (12 hours for waxy bases).
- Cell loading. Transfer product into the 50 mm cylindrical back extrusion cell to a depth of 30 mm using a scoop. Level the surface with a spatula. Avoid air entrainment.
- Instrument setup. Install the 5 kg load cell (10 kg for stiff pastes). Install the 45 mm back extrusion disc. Tare the load cell. Log in and recall the "Ointment Back Extrusion — USP <1724> Aligned" method.
- Positioning. Place the filled cell on the instrument platform, centred beneath the disc. Raise the platform until the disc is 10 mm above the product surface.
- Test execution. Press "Start". The disc descends at 2.0 mm/s until 0.1 N trigger, then at 1.0 mm/s through 25 mm travel, then withdraws at 10 mm/s. Data at 500 Hz is recorded to the audit trail.
- Parameter extraction. The software reports peak force, steady-state force (mean over 10–20 mm), and area under curve (total extrusion work). If the withdrawal curve was acquired, work of adhesion is also reported.
- Replicates. Remove and clean the cell and disc with IPA/water. Refill with fresh product (do not reuse the same aliquot). Repeat steps 2–6 for a minimum of five replicates.
- Reporting. The software computes mean ± SD and %RSD and generates a signed PDF with raw curves, parameters, and the operator's electronic signature. The supervisor counter-signs before batch release.